Deletion of exons 45–55, established using exon skipping therapy transformed DMD phenotypes to a milder BMD phenotype (53), from which 49.4% of DMD patients (72.1% of all DMD deletions) in our database would benefit. The gene discussed is DMD; the disease is Becker muscular dystrophy.